RETINOPATHY OF PREMATURITY
Clinical trials for RETINOPATHY OF PREMATURITY explained in plain language.
Never miss a new study
Get alerted when new RETINOPATHY OF PREMATURITY trials appear
Sign up with your email to follow new studies for RETINOPATHY OF PREMATURITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tiniest eyes: gentler doses tested for blinding infant condition
Disease control OngoingThis study is testing whether two lower doses of a medicine called bevacizumab can safely and effectively treat the most severe form of retinopathy of prematurity (ROP), an eye disease in very small premature babies. Doctors are comparing a very low dose (0.063 mg) to the standar…
Matched conditions: RETINOPATHY OF PREMATURITY
Phase: PHASE2 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
AI steps in to help spot blindness risk in preemies
Diagnosis OngoingThis study is testing a computer program (AI) called i-ROP DL to see if it helps eye doctors diagnose a serious condition called 'plus disease' in premature babies. Sixteen eye doctors will review about 300 sets of baby eye images, first on their own and then with the AI's help, …
Matched conditions: RETINOPATHY OF PREMATURITY
Phase: NA • Sponsor: Siloam Vision • Aim: Diagnosis
Last updated Apr 02, 2026 04:12 UTC